Association of Genetic Polymorphisms in TNFRSF11 with the Progression of Genetic Susceptibility to Gastric Cancer

Table 8

Clinic factors of rs9533156 polymorphism on gastric cancer development.

Group	TC + CC	TT	OR	95% CI	value
Tumor size
≥2 cm	360 (85.91)	125 (80.13)
<2 cm	59 (14.09)	31 (19.87)	1.751	1.078–2.845	0.022
Tumor location
Fundus	6 (1.70)	2 (1.85)
Antrum	256 (72.52)	82 (75.93)	0.961	0.190–4.853	0.962
Body of the stomach	91 (25.78)	24 (22.22)	0.791	0.150–4.171	0.676
Tumor differentiation
Well	12 (3.47)	2 (1.71)
Moderate	174 (50.29)	64 (54.70)	2.207	0.481–10.132	0.368
Poor	160 (46.24)	51 (43.59)	1.913	0.414–8.830	0.528
Pathological pattern
Signet-ring cell carcinoma	17 (4.20)	6 (4.55)
Both	5 (1.23)	4 (3.03)	0.178	0.183–0.991	0.407
Adenocarcinoma	383 (94.57)	122 (92.42)	0.903	0.348–2.340	0.833
Blood glucose
Hyperglycemia	114 (27.21)	16 (11.51)
Nonhyperglycemia	305 (72.79)	123 (88.49)	2.870	1.635–5.048	<0.001